Chronic administration of antipsychotics impede behavioral recovery after experimental traumatic brain injury.
about
Traumatic brain injury-induced cognitive and histological deficits are attenuated by delayed and chronic treatment with the 5-HT1A-receptor agonist buspironeFound in translation: Understanding the biology and behavior of experimental traumatic brain injuryCombination therapies for neurobehavioral and cognitive recovery after experimental traumatic brain injury: Is more better?Pharmacological interventions for agitation in patients with traumatic brain injury: protocol for a systematic review and meta-analysisPersistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesisNeuropsychiatry of pediatric traumatic brain injury.Biologic and plastic effects of experimental traumatic brain injury treatment paradigms and their relevance to clinical rehabilitation.Divergent long-term consequences of chronic treatment with haloperidol, risperidone, and bromocriptine on traumatic brain injury-induced cognitive deficitsEffects of computer assisted cognitive rehabilitation on brain wave, memory and attention of stroke patients: a randomized control trialFunctional Neuroimaging Distinguishes Posttraumatic Stress Disorder from Traumatic Brain Injury in Focused and Large Community Datasets.Functional neuroimaging with default mode network regions distinguishes PTSD from TBI in a military veteran population.Stimulation of functional recovery via the mechanisms of neurorepair by S-nitrosoglutathione and motor exercise in a rat model of transient cerebral ischemia and reperfusion.Administration of S-nitrosoglutathione after traumatic brain injury protects the neurovascular unit and reduces secondary injury in a rat model of controlled cortical impact.Emergency neurological life support: airway, ventilation, and sedation.Blood-brain barrier dysfunction following traumatic brain injury.5-hydroxytryptamine1A (5-HT1A) receptor agonists: A decade of empirical evidence supports their use as an efficacious therapeutic strategy for brain trauma.Comparable impediment of cognitive function in female and male rats subsequent to daily administration of haloperidol after traumatic brain injury.Elucidating opportunities and pitfalls in the treatment of experimental traumatic brain injury to optimize and facilitate clinical translation.A study on the mechanism by which MDMA protects against dopaminergic dysfunction after minimal traumatic brain injury (mTBI) in mice.Intermittent treatment with haloperidol or quetiapine does not disrupt motor and cognitive recovery after experimental brain trauma.Combining the Antipsychotic Drug Haloperidol and Environmental Enrichment after Traumatic Brain Injury Is a Double-Edged Sword.FeTPPS Reduces Secondary Damage and Improves Neurobehavioral Functions after Traumatic Brain Injury.Spontaneous recovery of traumatic brain injury-induced functional deficits is not hindered by daily administration of lorazepam.Relative to Typical Antipsychotic Drugs, Aripiprazole Is a Safer Alternative for Alleviating Behavioral Disturbances After Experimental Brain Trauma.Executive (dys)function after traumatic brain injury: special considerations for behavioral pharmacology
P2860
Q24633449-E88B008A-C985-403C-A55C-335EB94E86ADQ28396242-36B3636D-F4FE-4A2A-9474-40CCE6E7730AQ28397361-848AD916-A913-4251-A3B5-AEFAB1AAC168Q28821103-F15A228E-D6E6-4570-A4E1-C1B43ADBD06AQ33589580-EA3B234B-3DE0-47E0-9AF0-2E938321FF4BQ34404358-6CC391F4-5743-4BCC-9ADB-098741C85FCFQ35136513-1DD8C6EA-0B50-49AC-8367-1BD10841F099Q35376749-FC5B55B5-3117-4E5E-951C-2D2E223EF1D9Q35613558-5F9B851D-45E1-46D1-9DBF-6D5ED666C6B4Q35680006-673D06EC-EF9B-48B3-A6EE-163ECB14159FQ36074540-A9785C72-C5BD-4696-8995-EBD4A8F31EF7Q36318326-5F300375-C687-4838-AF56-3E69897F3B15Q37420533-BA70DC3B-4E08-40CC-A176-36B04FDED03AQ38042830-75054537-0871-4B09-8861-E6850C8EBEB8Q38333690-FF34BAE7-C654-4B93-B044-C8CF9C896266Q38650071-80B7AB4D-367C-4E0C-86C8-E8E379C23297Q38683606-4CBFEDBC-8C4F-49FE-8306-D00126B41244Q38747752-0BA0ECC3-FC40-428A-8382-B20C909F7FF8Q39202524-1C7581C1-9EA2-454A-B25B-FF8519A3D006Q39355321-C52628FD-559A-408D-A21F-701931312B61Q39921323-BEC08742-77EF-4F78-AAC8-66308AAC90BCQ41852720-CF9D8D0A-0206-4350-87C7-9B817AD64620Q47371361-C9C2C7AF-E05B-41B8-B409-3576FCFEDA29Q48713412-D98E9C5E-1194-4823-B715-DD682278FF46Q58739852-B971EA32-6FEF-4B82-BC28-A286DDD0BDF2
P2860
Chronic administration of antipsychotics impede behavioral recovery after experimental traumatic brain injury.
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Chronic administration of anti ...... mental traumatic brain injury.
@ast
Chronic administration of anti ...... mental traumatic brain injury.
@en
Chronic administration of anti ...... mental traumatic brain injury.
@nl
type
label
Chronic administration of anti ...... mental traumatic brain injury.
@ast
Chronic administration of anti ...... mental traumatic brain injury.
@en
Chronic administration of anti ...... mental traumatic brain injury.
@nl
prefLabel
Chronic administration of anti ...... mental traumatic brain injury.
@ast
Chronic administration of anti ...... mental traumatic brain injury.
@en
Chronic administration of anti ...... mental traumatic brain injury.
@nl
P2093
P2860
P1433
P1476
Chronic administration of anti ...... mental traumatic brain injury.
@en
P2093
Ann N Hoffman
Anthony E Kline
Jaime L Massucci
Ross D Zafonte
P2860
P304
P356
10.1016/J.NEULET.2008.10.076
P407
P577
2008-10-25T00:00:00Z